Real‐World Glycemic Outcomes of Open‐Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups

Qiong-Yan Lin Zi-Qing Lin P. Ling Ying Ni Meng-Yun Lei Yan-Li Cao Dai-Zhi Yang Wen Xu Hong-Rong Deng Yong-Wen Zhou Jin-Hua Yan

Aug 2026 · Diabetes, obesity and metabolism · Vol 28, pp. 10625 - 10635 · 0 citations · 36 references

Medicine

Abstract

To assess glycemic outcomes across different age groups and explore factors associated with glycemic target achievement during 12‐months open‐source android artificial pancreas (AAPS) use among people with type 1 diabetes (T1D).

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Aug 2026

Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST‐T1D Extension Study

To evaluate changes in glycaemic control following semaglutide discontinuation in adults with Type 1 diabetes and obesity who completed the ADJUST‐T1D randomised controlled trial.

Eslam Montaser, K. Bhasin, Davida F. Kruger et al. · Diabetes, obesity and metabo... · 0 citations

Open access Sep 2026

Continuous Glucose Monitoring Alert Settings and Glycemic Control in People With Diabetes

This cohort study evaluates whether continuous glucose monitoring (CGM) alert settings are differentially associated with glycemic control outcomes among people with type 1 and type 2 diabetes.

Ya-Guang Zheng, Stephen B. Johnson, Eduardo Iturrate et al. · JAMA Network Open · 0 citations

Open access Oct 2026

Association between Continuous Glucose Monitoring and Risk of Acute Diabetes-Related Complications in Pediatric Type 1 Diabetes Mellitus: A Nationwide Cohort Study (Diabetes Metab J 2026 Apr 22 [Epub]. https://doi.org/10.4093/dmj.2025.0794).

between continuous glucose monitoring and risk of acute diabetes-related complications in pediatric

Ji Yon Kim, Seohyun Kim, Jae Hyeon Kim · Diabetes & Metabolism Journa... · 0 citations

Open access Aug 2026

Depression and Long‐Term HbA1c Variability Are Additively Associated With Increased Risk of Cardiovascular–Renal Outcomes, Severe Hypoglycaemia and Mortality in Type‐2 Diabetes

Depression and long‐term HbA1c variability are associated with adverse outcomes in type‐2 diabetes (T2D), which may be related to suboptimal self‐management practices and health‐related quality of life (HRQoL).

K. Wong, E. W. Chow, E. Lau et al. · Diabetes/Metabolism Research... · 0 citations

Open access Aug 2026

Extended Use of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 1 Diabetes: 12‐Month Extension of a Randomized Controlled Trial

The Omnipod 5 Automated Insulin Delivery (AID) System is safe and effective for individuals managing Type 1 diabetes (T1D). Longer‐term studies may provide additional evidence of sustained effectiveness and safety of AID system use in T1D.

Éric Renard, Ruth S. Weinstock, A. Penfornis et al. · Endocrinology, Diabetes & Me... · 0 citations

Review Open access Sep 2026

Commercial Automated Insulin Delivery Systems in Type 1 Diabetes Pregnancy: Protocol for a Mixed‐Methods Systematic Review and Meta‐Analysis of Glycaemic, Perinatal, Psychosocial and Implementation Outcomes

Commercial automated insulin delivery (AID) systems are increasingly used in pregnancies complicated by Type 1 diabetes, but the evidence is dispersed across trials, observational studies, case series and qualitative research. Existing syntheses have largely emphasised glycaemic efficacy and selected perinatal outcomes...

Jie-Li Li, Elahe Sheklabadi, R. Goldstein et al. · Endocrinology, Diabetes & Me... · 0 citations